Table 1 Baseline demographic and clinical characteristics

Age, years

34.8 ± 3.6

32.9 ± 3.6

0.029

History of preeclampsia, n (%)

2 (5.4)

1 (2.8)

0.999

 Early onset

22 (59.5)

 Late onset

15 (40.5)

Peak body weight during pregnancy, kg

70.4 ± 11.8

65.6 ± 7.5

0.042 (0.108^b)

Primipara

24 (64.9)

24 (66.7)

0.871

Twins, n (%)

4 (10.8)

1 (2.8)

0.358

Gestational week at delivery

33.7 ± 3.0

37.7 ± 2.0

<0.001

Fetal birth weight, kg

1.79 ± 0.58

2.93 ± 0.52

<0.001

Waist-to-hip ratio

0.92 ± 0.05

0.92 ± 0.06

0.874

BMI, m²/kg

27.4 ± 5.0

25.0 ± 2.8

0.015 (0.050^b)

Mean CAVI^c

6.92 ± 1.69

6.53 ± 1.50

0.306 (0.032^b)

Hypertension^d, n (%)

2 (5.4)

0

0.494

Diabetes mellitus^e, n (%)

4 (10.8)

0

0.115

SBP, mmHg

142.4 ± 12.7

111.4 ± 10.5

< 0.001

DBP, mmHg

83.9 ± 9.3

63.2 ± 7.8

< 0.001

Hemoglobin, mg/dL

12.0 ± 2.0

11.4 ± 1.8

0.164

Total cholesterol, mg/dL

232.6 ± 49.6

208.6 ± 46.3

0.036

HDL cholesterol, mg/dL

59.9 ± 14.6

62.6 ± 13.1

0.419

LDL cholesterol, mg/dL

126.2 ± 33.0

112.2 ± 33.7

0.082 (0.017^b)

Triglyceride, mg/dL

255.6 ± 92.5

213.6 ± 60.5

0.026 (0.061^b)

Creatinine, mg/dL

0.693 ± 0.255

0.532 ± 0.092

0.001 (0.007^b)

AST, IU/L

31.0 ± 17.2

17.9 ± 7.6

< 0.001

ALT, IU/L

27.0 ± 26.9

11.4 ± 6.2

0.002 (<0.001^b)

Hypertension treatment, n (%)

23 (62.2%)

0%

<0.001

 Single drug

13 (56.5)

 Two drugs

8 (34.8)

 Three drugs

2 (8.7)

 CCB

23 (100%)

 BB

2 (8.7%)